Phospho-SMAD2 (Ser465) Antibody

Basic Research Questions

• What is Phospho-SMAD2 (Ser465/467) and why is it important in TGF-β signaling research?

  Phospho-SMAD2 (Ser465/467) refers to SMAD2 protein that has been specifically phosphorylated at serine residues 465 and 467 in its C-terminal region. This post-translational modification serves as a critical activation mechanism in TGF-β signaling. Following TGF-β receptor activation, the receptor kinase TGF-β R1 phosphorylates these specific serine residues on SMAD2 . This phosphorylation event enables SMAD2 to form heteromeric complexes with SMAD4, translocate to the nucleus, and regulate gene transcription .

  The importance of this phosphorylation lies in its role as the primary activation mechanism for the canonical TGF-β pathway, which controls numerous cellular processes including apoptosis, migration, differentiation, immune/inflammatory responses, and extracellular matrix remodeling .

• How does phosphorylation of SMAD2 at Ser465/467 differ functionally from phosphorylation at other sites like Ser245/250/255?

  The phosphorylation of SMAD2 at different sites produces opposing functional outcomes:

  Phosphorylation Site	Kinase Responsible	Functional Outcome	Subcellular Localization
  Ser465/467 (C-terminus)	TGF-β receptor kinase	Activation; promotes complex formation with SMAD4	Nuclear translocation
  Ser245/250/255 (Linker region)	MAP kinase	Inhibition; prevents signal transduction	Cytoplasmic retention

  As indicated in source material, "Phosphorylation of serines 465 and 467 indicates SMAD2 activation and nuclear localization; whereas, phosphorylation of serines 245, 250, and 255 is inhibitory and leads to retention of SMAD2 in the cytoplasm" . This differential phosphorylation represents a key regulatory mechanism that allows for integration of multiple signaling inputs to modulate TGF-β pathway activity .

• What is the order of phosphorylation events at the Ser465/467 sites, and why is this important?

  Research has revealed that phosphorylation of SMAD2 at Ser465 and Ser467 occurs in an obligate sequence. Specifically, "phosphorylation of Ser465 requires that Ser467 be phosphorylated" . This sequential phosphorylation is critical because:

  • It ensures proper conformational changes needed for SMAD2 activation

  • Both phosphorylation sites are necessary for stable interaction with SMAD4

  • The dual phosphorylation creates a specific recognition site for SMAD4 binding

  • Mutation of either site results in dominant-negative inhibition of TGF-β signaling

  This ordered phosphorylation represents a regulatory checkpoint in the signaling pathway, preventing inappropriate activation of SMAD2 and ensuring signal fidelity.

• What detection methods can be used to analyze Phospho-SMAD2 (Ser465/467) in experimental systems?

  Several methodologies are available to researchers for detecting and quantifying Phospho-SMAD2 (Ser465/467):

  Method	Application	Sensitivity	Sample Requirements
  Western Blotting	Protein expression analysis	Detects endogenous levels	Cell/tissue lysates (25μg protein)
  HTRF Cell-Based Assay	Quantitative detection	32× more sensitive than Western blot	16μL sample volume
  ChIP-Seq	Genome-wide binding analysis	Maps binding sites at high resolution	Chromatin preparations
  Immunofluorescence	Subcellular localization	Visualizes cellular distribution	Fixed cells/tissues

  When selecting an appropriate method, researchers should consider factors such as the need for quantification, spatial information, throughput requirements, and available sample quantity .

• What are the essential controls when validating Phospho-SMAD2 (Ser465/467) antibody specificity?

  Proper validation of Phospho-SMAD2 (Ser465/467) antibodies requires several critical controls:

  • Positive control: TGF-β or Activin-stimulated cells showing increased signal (e.g., HeLa cells treated with TGF-β for 30 minutes)

  • Negative control: Serum-starved cells or cells treated with TGF-β receptor inhibitor SB431542

  • Specificity control: Comparison with total SMAD2 antibody to demonstrate phospho-specificity

  • Peptide competition: Using phosphorylated vs. non-phosphorylated peptides containing the Ser465/467 sequence

  • Genetic validation: Using SMAD2 knockdown cells or SMAD2 S465A/S467A mutant-expressing cells

  Without these controls, researchers risk misinterpreting non-specific signals or cross-reactivity with other phosphorylated proteins.

Advanced Research Questions

• How can researchers distinguish between transient versus sustained SMAD2 phosphorylation and what is the biological significance of these dynamics?

  Distinguishing between transient and sustained SMAD2 phosphorylation requires careful kinetic analysis and specialized experimental approaches:

  Methodological approach:

  • Perform detailed time-course experiments (30 min to 48 hours post-stimulation)

  • Use both Western blot and quantitative phospho-specific ELISA/HTRF assays

  • Apply receptor kinase inhibitors (like SB431542) at different time points after initial stimulation

  • Compare results across multiple cell types with known differential responses

  Research has shown that in human lung fibroblasts, "maximal phosphorylation of Smad2 occurs at 30–60 minutes and then declines after 3 hours of TGF-β treatment," but importantly, "Smad2 remained partially phosphorylated (by ~50%) at 3–48 hours, as compared with the maximum phosphorylation observed at 1 hour" . This sustained phosphorylation was found to be essential for myofibroblast differentiation.

  Biological significance:
  The temporal dynamics of SMAD2 phosphorylation determine distinct cellular outcomes:

  • Transient phosphorylation: Often associated with cell proliferation responses

  • Sustained phosphorylation: Required for terminal differentiation processes (e.g., myofibroblast differentiation)

  • Oscillatory patterns: May enable cells to maintain sensitivity to changing ligand concentrations

  The differential duration of phosphorylation allows cells to distinguish between acute versus chronic TGF-β signaling and to coordinate appropriate biological responses .

• What factors influence the stability of Phospho-SMAD2 (Ser465/467) in experimental systems and how can dephosphorylation be minimized?

  Multiple factors affect Phospho-SMAD2 (Ser465/467) stability:

  Factors decreasing stability:

  • Endogenous phosphatases (particularly PP1c)

  • E3 ubiquitin ligases (Smurf2, Arkadia) targeting phosphorylated SMAD2 for degradation

  • Non-physiological temperature during sample processing

  • Absence of phosphatase inhibitors in lysis buffers

  Strategies to preserve phosphorylation:

  1. Buffer optimization: Include phosphatase inhibitor cocktails containing sodium fluoride, sodium orthovanadate, and β-glycerophosphate

  2. Temperature control: Process samples rapidly at 4°C

  3. Protein extraction method: Use direct lysis in SDS sample buffer for immediate denaturation of phosphatases

  4. Genetic approaches: Consider knockdown of specific phosphatases in model systems

  5. Chemical approaches: Pre-treat cells with phosphatase inhibitors like okadaic acid

  Research has demonstrated that "in the absence of Arkadia, P-Smad2 levels were not significantly changed" after 90 minutes of receptor inhibition, while in wild-type cells, P-Smad2 levels declined by 40-60% within 30 minutes . This indicates that targeted inhibition of specific degradation pathways can significantly enhance phospho-SMAD2 stability.

• How do graded levels of TGF-β/Activin signaling affect Phospho-SMAD2 (Ser465/467) genomic binding patterns and target gene regulation?

  Graded TGF-β/Activin signaling produces complex, non-linear effects on Phospho-SMAD2 genomic binding and gene regulation:

  Research using ChIP-Seq analysis revealed that "phospho-Smad2 binds to and regulates distinct subsets of target genes in a dose-dependent manner" . Specifically:

  • Low signaling conditions (SB431542 treatment): Phospho-SMAD2 primarily binds to genes involved in trophectodermal differentiation

  • Medium signaling conditions (basal activity): Phospho-SMAD2 occupies genes related to self-renewal and pluripotency, including direct binding to the Oct4 promoter

  • High signaling conditions (Activin stimulation): Phospho-SMAD2 targets genes associated with mesendodermal lineage specification

  This differential binding is not simply quantitative but qualitative - different signaling levels recruit Phospho-SMAD2 to entirely different genomic locations .

  The molecular basis for this selective binding involves:

  • Concentration-dependent cooperative binding with other transcription factors

  • Signal-strength dependent chromatin accessibility changes

  • Differential association with transcriptional cofactors based on phosphorylation levels

  • Competition with inhibitory SMADs at certain genomic loci

  These findings explain how quantitative differences in signaling can be translated into qualitative differences in cell fate decisions during development and in stem cell systems .

• How does cross-talk between Rho/ROCK and TGF-β signaling pathways affect SMAD2 phosphorylation patterns?

  Recent research has uncovered complex cross-talk between Rho/ROCK and TGF-β signaling pathways that affects both C-terminal and linker region phosphorylation of SMAD2:

  Key experimental findings:

  • Cultivation of mesenchymal stem cells (MSCs) on collagen matrices reduced phosphorylation of the SMAD2 linker region (Ser245/250/255) compared to monolayer culture

  • ROCK inhibition with Y-27632 had differential effects on SMAD2 versus SMAD3 linker phosphorylation

  • The combination of ROCK inhibition and TGF-β3 stimulation supported tenogenic differentiation

  Mechanistic interactions:

  1. ROCK inhibition modulates SMAD2/3 subcellular localization

  2. Extracellular matrix composition (collagen) affects SMAD2 linker phosphorylation

  3. Integration of mechanical signaling (via Rho/ROCK) with biochemical TGF-β signals occurs at the level of SMAD phosphorylation

  This interplay is particularly important in mechanosensitive cell types and differentiation processes where both chemical signals and physical forces regulate cell fate decisions .

• What strategies can resolve contradictory results when comparing Phospho-SMAD2 (Ser465/467) levels across different experimental systems?

  Contradictory results when analyzing Phospho-SMAD2 (Ser465/467) can arise from multiple sources. A systematic troubleshooting approach includes:

  Common sources of variation:

  1. Antibody cross-reactivity: Some antibodies may detect both Phospho-SMAD2 and Phospho-SMAD3 due to sequence similarity

  2. Cell type-specific phosphorylation dynamics: Different cell types show variable kinetics of phosphorylation/dephosphorylation

  3. Basal phosphorylation levels: Some cell lines exhibit higher constitutive SMAD2 phosphorylation

  4. Technical variations: Sample preparation methods significantly impact phosphorylation preservation

  Resolution strategies:

  • Antibody validation: Use both phospho-specific (Ser465/467) and total SMAD2 antibodies in parallel

  • Multiple detection methods: Compare results from Western blot, ELISA, and cellular assays

  • Genetic controls: Include SMAD2 knockdown or knockout samples as negative controls

  • Normalized quantification: Express results as phospho-SMAD2/total SMAD2 ratio

  • Time-course experiments: Assess both peak phosphorylation and duration/decay kinetics

  Research has shown that "SMAD2 is a cytoplasmic protein and can be phosphorylated by the activated type I receptor," while "SMAD3 localizes in the nucleus even under the static state," which contributes to their "differential sensitivity in relaying TGFβ signaling" . Understanding these intrinsic differences between SMAD2 and SMAD3 is essential for proper interpretation of experimental results.